People · Operator
Named in public records as an officer, director or promoter · active 2013–2022 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zettics, Inc. | — | Other Technology | Series A | $37.6M | $83.2M | 2013 |
| Ambergen, Inc. | — | Biotechnology | Series A | $5.0M | $77.1M | 2022 |
John GIllespie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John GIllespie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Erik Benson | 1 | 13 |
| Edward Anderson | 1 | 8 |
| TOM HUSEBY | 1 | 6 |
| Peter Finn | 1 | 5 |
| Daniel Hess | 1 | 4 |
| Paul Magelli | 1 | 4 |
| Liping Fan | 1 | 4 |
| John St. Amand | 1 | 4 |
| Kevin Spain | 1 | 3 |
| Michael Crane | 1 | 3 |
| Joe Levy | 1 | 3 |
| Nerissa Robert | 1 | 3 |
| Beau Laskey | 1 | 2 |
| Michael Libes | 1 | 2 |
| Steven Bailey | 1 | 2 |
| Hans Pusch | 1 | 2 |
| Aaron McKee | 1 | 2 |
| Ian Herbert-Jones | 1 | 2 |
| Stephen Douglas | 1 | 2 |
| Sterling Wilson | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.